Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension

doi:10.4330/wjc.v5.i5.132

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3832)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

330

HTML

2993

Figures (1-1)

249

Tables (1-6)

260

Sum=3832

May 26, 2013 (publication date) through Dec 18, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Cardiol. May 26, 2013; 5(5): 132-140
Published online May 26, 2013. doi: 10.4330/wjc.v5.i5.132

Table 1 Antropometric, clinical and biochemical characteristics of study participants (mean ± SD) n (%)

Characteristics
Age, yr	65.1 ± 9.8
BMI, kg/m²	26.2 ± 4.7
SBP, mm/Hg	138 ± 19
DBP, mm/Hg	83 ± 9
Cholesterol, mg/dL	234 ± 49
TG, mg/dL	125 ± 70
HDL cholesterol, mg/dL	66 ± 11
LDL cholesterol, mg/dL	143 ± 47
EH	120 (61)
LVH	53 (27)
CHD	45 (23)
Type 2 diabetes	23 (12)
Myocardial infarction	8 (4)
Family history of EH	75 (38)
Family history of myocardial infarction	51 (26)

BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; EH: Essential hypertension; LVH: Left ventricular hypertrophy; CHD: Coronary heart disease; TG: Triglycerides; HDL: High density lipoproteins; LDL: Low density lipoproteins.

Table 2 Antropometric, clinical and biochemical characteristics of study participants from the 1^st and 2^nd quartiles of distribution of 15059G>A heteroplasmy level n (%)

Characteristics	15059G>A heteroplasmy level¹		P value
Characteristics	Quartile 1 (n = 49)	Quartile 4 (n = 48)
Age, yr	60.1 ± 7.1	66.2 ± 9.9	0.001
BMI, kg/m²	26.4 ± 4.5	27.1 ± 5.1	0.41
SBP, mm/Hg	132 ± 18	143 ± 22	0.022
DBP, mm/Hg	83 ± 12	84 ± 12	0.50
Cholesterol, mg/dL	228 ± 42	243 ± 43	0.10
TG, mg/dL	112 ± 57	141 ± 61	0.021
HDL cholesterol, mg/dL	66 ± 14	68 ± 19	0.69
LDL cholesterol, mg/dL	140 ± 40	147 ± 44	0.44
EH	22 (45)	30 (63)	0.17
LVH	13 (27)	13 (27)	0.97

¹Data are mean ± SD. BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; EH: Essential hypertension; LVH: Left ventricular hypertrophy; TG: Triglycerides; HDL: High density lipoproteins; LDL: Low density lipoproteins.

Table 3 Antropometric, clinical and biochemical characteristics of coronary heart disease patients from the 1^st and 2^nd quartiles of distribution of 15059G>A heteroplasmy level n (%)

Characteristics	15059G>A heteroplasmy level¹		P value
Characteristics	Quartile 1 (n = 11)	Quartile 4 (n = 10)
Age, yr	63.2 ± 7.0	72.9 ± 8.7	P value	0.011
BMI, kg/m²	27.2 ± 6.2	26.1 ± 5.9	0.69
SBP, mmHg	129 ± 22	153 ± 22	0.03
DBP, mmHg	80 ± 12	85 ± 13	0.32
Cholesterol, mg/dL	224 ± 54	236 ± 49	0.59
TG, mg/dL	130 ± 77	121 ± 56	0.78
HDL cholesterol, mg/dL	62 ± 15	69 ± 15	0.39
LDL cholesterol, mg/dL	136 ± 47	143 ± 42	0.69
EH	7 (64)	7 (70)	0.86
LVH	4 (36)	4 (40)	0.68

Table 4 Antropometric, clinical and biochemical characteristics of CHD-free study participants from the 1^st and 2^nd quartiles of distribution of 15059G>A heteroplasmy level n (%)

Characteristics	15059G>A heteroplasmy level¹		P value
Characteristics	Quartile 1 (n = 38)	Quartile 4 (n = 37)
Age, yr	59.4 ± 7.2	64.7 ± 8.8	P value	0.005
BMI, kg/m²	26.0 ± 4.0	27.4 ± 5.3	0.2
SBP, mmHg	132 ± 14	141 ± 21	0.17
DBP, mmHg	84 ± 11	84 ± 10	0.99
Cholesterol, mg/dL	231 ± 41	246 ± 47	0.14
TG, mg/dL	106 ± 46	147 ± 61	0.003
HDL cholesterol, mg/dL	67 ± 14	67 ± 18	0.99
LDL cholesterol, mg/dL	143 ± 37	150 ± 42	0.44
EH	15 (39)	23 (62)	0.19
LVH	10 (26)	10 (27)	0.98

Table 5 Comparison of antropometric, clinical and biochemical characteristics of study participants from “low heteroplasmy” and “high heteroplasmy” groups n (%)

Characteristics	15059G>A heteroplasmy level¹		P value
Characteristics	Low (n = 99)	High (n = 97)
Age, yr	60.2 ± 8.4	68.6 ± 8.4	P value	< 0.001
BMI, kg/m²	26.3 ± 4.1	27.0 ± 5.0	0.52
SBP, mmHg	133 ± 16	142 ± 18	0.024
DBP, mmHg	82 ± 11	84 ± 11	0.39
Cholesterol, mg/dL	232 ± 48	241 ± 48	0.27
TG, mg/dL	118 ± 56	135 ± 62	0.065
HDL cholesterol, mg/dL	67 ± 14	66 ± 15	0.92
LDL cholesterol, mg/dL	141 ± 42	148 ± 44	0.49
EH	51 (52)	69 (71)	0.033
LVH	20 (20)	33 (34)	0.1

Table 6 Association between the 15059G>A heteroplasmy level and essential hypertension prevalence

15059G>A heteroplasmy level	No hypertension, n	Hypertension, n	Odds ratio (95%CI)	P value
Low (< 31%)	51	51
High (> 31%)	25	69	2.76 (1.45-5.27)	0.019
Total	76	120

Citation: Sobenin IA, Chistiakov DA, Sazonova MA, Ivanova MM, Bobryshev YV, Orekhov AN, Postnov AY. Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension. World J Cardiol 2013; 5(5): 132-140
URL: https://www.wjgnet.com/1949-8462/full/v5/i5/132.htm
DOI: https://dx.doi.org/10.4330/wjc.v5.i5.132